We also found that TIGIT was highly expressed in basal-like and HER2-overexpressing subtypes of invasive breast cancer and used Kaplan-Meier survival analysis to verify the relationship between TIGIT and invasive breast cancer survival. This evidence concerns the gene ERBB2 and invasive breast carcinoma.